Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of Oliceridine (TRV130) in Acute Pain
NCT02656875Phase 3Completed
- Sponsor
- Trevena, Inc.
- Start
- Dec 2015
- Primary completion
- May 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of oliceridine in acute pain, sponsored by Trevena, Inc.. Started Dec 2015; status: completed.
02
Drugs
oliceridine
03
Conditions
acute pain
Beyond the preview
Go deeper on NCT02656875.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02656875.